Akila E, Sunitha Th, Sahana Hc, Amritha Dev Sudevan, Narayanaswamy Vb
Ayurvedic practitioners utilise Pashanabheda as an anti-urolithiatic. The root of Homonoia retusa (Euphorbiaceae), which grows in the Indian town of Tirupathi, was chosen for this study's screening for its antioxidant and anti-urolithiatic properties. The hydrogen peroxide assay (H2O2), ferric reducing antioxidant power (FRAP), and 2,2′-diphenyl-1-picrylhydrazyl (DPPH) techniques were utilised to assess antioxidant activity. The anti-urolithiatic activity was evaluated by nucleation and aggregation assay by adding 0.01 M sodium oxalate solutions that caused the crystallisation of Calcium oxalate. By measuring turbidity in the presence or absence of extract at 620 nm using a spectrophotometer, the effect of extract (200, 400, 600, 800, and 1000 µg/ml) was investigated. According to the result, aqueous root extract can prevent crystal growth and aggregation more than methanol-based root extract.
{"title":"IN VITRO INVESTIGATION OF ANTIOXIDANT AND ANTI-UROLITHIATIC ACTIVITY OF HOMONOIA RETUSA ROOTS","authors":"Akila E, Sunitha Th, Sahana Hc, Amritha Dev Sudevan, Narayanaswamy Vb","doi":"10.7897/2277-4343.15121","DOIUrl":"https://doi.org/10.7897/2277-4343.15121","url":null,"abstract":"Ayurvedic practitioners utilise Pashanabheda as an anti-urolithiatic. The root of Homonoia retusa (Euphorbiaceae), which grows in the Indian town of Tirupathi, was chosen for this study's screening for its antioxidant and anti-urolithiatic properties. The hydrogen peroxide assay (H2O2), ferric reducing antioxidant power (FRAP), and 2,2′-diphenyl-1-picrylhydrazyl (DPPH) techniques were utilised to assess antioxidant activity. The anti-urolithiatic activity was evaluated by nucleation and aggregation assay by adding 0.01 M sodium oxalate solutions that caused the crystallisation of Calcium oxalate. By measuring turbidity in the presence or absence of extract at 620 nm using a spectrophotometer, the effect of extract (200, 400, 600, 800, and 1000 µg/ml) was investigated. According to the result, aqueous root extract can prevent crystal growth and aggregation more than methanol-based root extract.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"46 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140414977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In Ayurveda, menstruation is referred to as artava, an upadhatu formed during rasa dhatu formation. It usually begins at the age of twelve (Rajapravritti kala) and ends at the age of fifty (Rajonivritti kala) in women. The menstrual cycle is a cyclical bleeding that occurs every month for three to five days in reproductive-age women. The artavachakra is divided into three phases: ritu kala, rajavyateeta kala, and rajasrava kala, which correspond to menstrual bleeding, the proliferative phase, and the secretory phase of the menstrual cycle. These three phases are controlled by the three doshas, and any imbalance in them may lead to menstrual abnormalities. The equilibrium of the three doshas results in a regular menstrual cycle. The aggregation or vriddhi of Kapha, Pitta, and Vata occur in ritu kala, rituvyateeta kala and rajasrava kala, respectively, along with the chaya and shamana of other doshas.
{"title":"A REVIEW ON THE CIRCADIAN RHYTHM OF TRIDOSHA IN THE MENSTRUAL CYCLE (ARTAVACHAKRA)","authors":"Reshma M, Swati N Khandale, AS Baghel, S. Donga","doi":"10.7897/2277-4343.15123","DOIUrl":"https://doi.org/10.7897/2277-4343.15123","url":null,"abstract":"In Ayurveda, menstruation is referred to as artava, an upadhatu formed during rasa dhatu formation. It usually begins at the age of twelve (Rajapravritti kala) and ends at the age of fifty (Rajonivritti kala) in women. The menstrual cycle is a cyclical bleeding that occurs every month for three to five days in reproductive-age women. The artavachakra is divided into three phases: ritu kala, rajavyateeta kala, and rajasrava kala, which correspond to menstrual bleeding, the proliferative phase, and the secretory phase of the menstrual cycle. These three phases are controlled by the three doshas, and any imbalance in them may lead to menstrual abnormalities. The equilibrium of the three doshas results in a regular menstrual cycle. The aggregation or vriddhi of Kapha, Pitta, and Vata occur in ritu kala, rituvyateeta kala and rajasrava kala, respectively, along with the chaya and shamana of other doshas.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"41 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140416028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
When the mucus membrane within the sinuses becomes infected and inflamed, the condition is called Rhinosinusitis. The causative factors are uncommon; we can consider some causative factors like viral upper respiratory tract infections, bacterial infections, allergy, adenoid vegetation, airway pollutants, some structural anomalies, gastroesophageal reflux disease, immunologic defects, and cystic fibrosis. A disease termed Pratishyaya and Pinus, mentioned in different Ayurvedic Samhitas, has similar symptoms to Rhinosinusitis. Forty patients whose medical history, physical examination available imaging reports, and blood parameters suggested chronic Rhinosinusitis were recruited in the study. Ayushakti herbal medicines, along with Breathe easy Nasya treatment, were administered to the patients for 90 days and were found effective and safe without any side effects. If chronic Rhinosinusitis can be treated successfully, acute cases directly seeking this therapy can be cured and we can restrict them from going into the chronic phase.
{"title":"EFFICACY OF AYUSHAKTI HERBAL REMEDIES AND BREATHE EASY NASYA THERAPY IN THE MANAGEMENT OF RHINOSINUSITIS (PINUS)","authors":"Smita P. Naram, Deepak Mahajan","doi":"10.7897/2277-4343.15111","DOIUrl":"https://doi.org/10.7897/2277-4343.15111","url":null,"abstract":"When the mucus membrane within the sinuses becomes infected and inflamed, the condition is called Rhinosinusitis. The causative factors are uncommon; we can consider some causative factors like viral upper respiratory tract infections, bacterial infections, allergy, adenoid vegetation, airway pollutants, some structural anomalies, gastroesophageal reflux disease, immunologic defects, and cystic fibrosis. A disease termed Pratishyaya and Pinus, mentioned in different Ayurvedic Samhitas, has similar symptoms to Rhinosinusitis. Forty patients whose medical history, physical examination available imaging reports, and blood parameters suggested chronic Rhinosinusitis were recruited in the study. Ayushakti herbal medicines, along with Breathe easy Nasya treatment, were administered to the patients for 90 days and were found effective and safe without any side effects. If chronic Rhinosinusitis can be treated successfully, acute cases directly seeking this therapy can be cured and we can restrict them from going into the chronic phase.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"2003 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140416491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The case study outlines the successful Ayurvedic management of Bell's palsy, referred to as Ardita in Ayurveda. The 46-year-old male patient presented with sudden onset drooping of the right upper eyelid, prominent right nasolabial fold, and dryness in the right eye after travelling. These symptoms are consistent with facial muscle weakness, which is characteristic of Bell's palsy. In Ayurveda, Ardita is correlated with the vitiation of Vata dosha, leading to facial distortion. The treatment approach adopted in this case was shamana chikitsa, a method focused on pacifying the aggravated dosha. Additionally, the Tarpana procedure, belonging to Netra-kriya-kalpana (ocular therapies), was employed along with mild ocular exercises. The shamana and Tarpana procedures were initiated from the first day of the treatment. After two weeks, there was a significant improvement in the gradation of Bell's palsy, resulting in a normal palpebral aperture of the eye. Notably, the treatment approach followed Ayurvedic principles and did not involve the use of oral steroids. This case study contributes to exploring and developing Ayurvedic treatment modalities for Bell's palsy. The successful outcome, without adverse effects, highlights the potential effectiveness of Ayurvedic interventions in managing facial muscle weakness. The emphasis on shamana and specific ocular therapies aligns with the holistic approach of Ayurveda, addressing the root cause of the condition and promoting overall well-being. In conclusion, this case study provides valuable insights into Ayurvedic management of Bell's palsy, showcasing the potential of traditional Ayurvedic principles and therapies in treating facial muscle weakness, enhancing confidence and preventing long-term facial damage.
{"title":"A CASE STUDY ON RESTORING FACIAL SYMMETRY: AN AYURVEDIC APPROACH TO ARDITA (BELL’S PALSY)","authors":"Pooja Prabhu, Hemant Paradkar, Subodh Pal, Anaya Pathrikar, Nitin Kamat","doi":"10.7897/2277-4343.1518","DOIUrl":"https://doi.org/10.7897/2277-4343.1518","url":null,"abstract":"The case study outlines the successful Ayurvedic management of Bell's palsy, referred to as Ardita in Ayurveda. The 46-year-old male patient presented with sudden onset drooping of the right upper eyelid, prominent right nasolabial fold, and dryness in the right eye after travelling. These symptoms are consistent with facial muscle weakness, which is characteristic of Bell's palsy. In Ayurveda, Ardita is correlated with the vitiation of Vata dosha, leading to facial distortion. The treatment approach adopted in this case was shamana chikitsa, a method focused on pacifying the aggravated dosha. Additionally, the Tarpana procedure, belonging to Netra-kriya-kalpana (ocular therapies), was employed along with mild ocular exercises. The shamana and Tarpana procedures were initiated from the first day of the treatment. After two weeks, there was a significant improvement in the gradation of Bell's palsy, resulting in a normal palpebral aperture of the eye. Notably, the treatment approach followed Ayurvedic principles and did not involve the use of oral steroids. This case study contributes to exploring and developing Ayurvedic treatment modalities for Bell's palsy. The successful outcome, without adverse effects, highlights the potential effectiveness of Ayurvedic interventions in managing facial muscle weakness. The emphasis on shamana and specific ocular therapies aligns with the holistic approach of Ayurveda, addressing the root cause of the condition and promoting overall well-being. In conclusion, this case study provides valuable insights into Ayurvedic management of Bell's palsy, showcasing the potential of traditional Ayurvedic principles and therapies in treating facial muscle weakness, enhancing confidence and preventing long-term facial damage.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"31 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140413899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hyperthyroidism or thyrotoxicosis is a disorder of the thyroid gland resulting in hypersecretion of thyroid hormones, namely T3 and T4, that, in turn, result in the diminished secretion of thyroid-stimulating hormone. All these events lead to hyperactivation of metabolism and sympathetic nervous system, resulting in symptoms of increased body secretions, diarrhoea, palpitation, raised blood pressure, fatigue and intolerance to heat. Also, there are symptoms of increased appetite and weight loss and menstrual and erectile dysfunction. In Ayurveda, there is no concept of hormones. On an Ayurveda basis, body and disease are dosa, dhatu and mala, so after reviewing Ayurveda text, Hyperthyroidism seems to be aggravated Pitta-Vata disorder leading to teekshana agni (increased digestive fire) and ati- mala pravritti (frequent stools), ati sweda (excessive sweating), vishrata (smell of raw meat), alpa sukra (oligospermia), alpa putra (less progeny) etc. A 25-year-old female, already diagnosed with Hyperthyroidism, came to OPD of Kayachikitsa CBPACS. On evaluation, it seems that the patient has symptoms of aggregated Pitta Vata; with Ayurvedic medicine, the patient is completely cured and values of TSH raised from 0.030 µIU/ml to TSH- 4.01 µIU/ml within normal limits.
{"title":"A CLINICAL CASE STUDY OF HYPERTHYROIDISM AND ITS AYURVEDIC MANAGEMENT","authors":"Shweta Bisht, Sonam Chauhan, N. R. Singh","doi":"10.7897/2277-4343.1512","DOIUrl":"https://doi.org/10.7897/2277-4343.1512","url":null,"abstract":"Hyperthyroidism or thyrotoxicosis is a disorder of the thyroid gland resulting in hypersecretion of thyroid hormones, namely T3 and T4, that, in turn, result in the diminished secretion of thyroid-stimulating hormone. All these events lead to hyperactivation of metabolism and sympathetic nervous system, resulting in symptoms of increased body secretions, diarrhoea, palpitation, raised blood pressure, fatigue and intolerance to heat. Also, there are symptoms of increased appetite and weight loss and menstrual and erectile dysfunction. In Ayurveda, there is no concept of hormones. On an Ayurveda basis, body and disease are dosa, dhatu and mala, so after reviewing Ayurveda text, Hyperthyroidism seems to be aggravated Pitta-Vata disorder leading to teekshana agni (increased digestive fire) and ati- mala pravritti (frequent stools), ati sweda (excessive sweating), vishrata (smell of raw meat), alpa sukra (oligospermia), alpa putra (less progeny) etc. A 25-year-old female, already diagnosed with Hyperthyroidism, came to OPD of Kayachikitsa CBPACS. On evaluation, it seems that the patient has symptoms of aggregated Pitta Vata; with Ayurvedic medicine, the patient is completely cured and values of TSH raised from 0.030 µIU/ml to TSH- 4.01 µIU/ml within normal limits.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"2007 18","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140416457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pain, said to be one of nature’s earliest signs of morbidity and is also one of the most typical presentations seen in medical practice, brings disturbance in the equilibrium state of a person. In order to manage such conditions, several drugs are available in the present era. Among them, some are expensive, and some have side effects such as dyspepsia and gastrointestinal bleeding, burning sensations, etc. For relieving pain, Acharya Charaka mentioned Vedanasthapana Daseimani Gana (Group of 10 Drugs), of which Mocarasa (Salmalia malabarica Dc.) is one among them. This study is taken up to evaluate the Vedanasthapana (Analgesic) karma of Mocarasa on albino mice using Eddy’s hot plate method. The Eddy’s Hot plate method is followed with three groups of Albino mice (6 mice in each group) as control group, standard drug group and trial drug group. Distilled water is fed to the control group, Mocarasa kwatha (decoction) for the trial drug group and Diclofenac sodium for the standard drug group. Statistically, the analgesic effect in the trial drug started gradually at 60 min and continued up to 120 min. Meanwhile, the standard group showed immediate onset of action at 15 min duration and progressively increased up to 120 min. The trial drug and the standard drug showed insignificant differences, which reveals that both have similar analgesic activity.
{"title":"EVALUATION OF VEDANASTHAPANA (ANALGESIC) EFFECT OF MOCARASA: SHALMALI NIRYASA (SALMALIA MALABARICA – GUM DC)","authors":"Huddar Shreedevi, Anup Kumar Elleri, Devaraj C","doi":"10.7897/2277-4343.15110","DOIUrl":"https://doi.org/10.7897/2277-4343.15110","url":null,"abstract":"Pain, said to be one of nature’s earliest signs of morbidity and is also one of the most typical presentations seen in medical practice, brings disturbance in the equilibrium state of a person. In order to manage such conditions, several drugs are available in the present era. Among them, some are expensive, and some have side effects such as dyspepsia and gastrointestinal bleeding, burning sensations, etc. For relieving pain, Acharya Charaka mentioned Vedanasthapana Daseimani Gana (Group of 10 Drugs), of which Mocarasa (Salmalia malabarica Dc.) is one among them. This study is taken up to evaluate the Vedanasthapana (Analgesic) karma of Mocarasa on albino mice using Eddy’s hot plate method. The Eddy’s Hot plate method is followed with three groups of Albino mice (6 mice in each group) as control group, standard drug group and trial drug group. Distilled water is fed to the control group, Mocarasa kwatha (decoction) for the trial drug group and Diclofenac sodium for the standard drug group. Statistically, the analgesic effect in the trial drug started gradually at 60 min and continued up to 120 min. Meanwhile, the standard group showed immediate onset of action at 15 min duration and progressively increased up to 120 min. The trial drug and the standard drug showed insignificant differences, which reveals that both have similar analgesic activity.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"587 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140417401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gallbladder cancer (GBC) arises from the cystic duct and gallbladder lining, presenting as a thickening in the bile duct wall or a diffuse mass. Arbuda and Gulma are considered malignant tumours in Ayurveda. Acharya Charaka associates Gulma, a type of shotha, with the pittashaya (gall bladder) among the five adhishthans. Acharya Sushruta defines Gulma as "any granthi between hruday and Basti pradesh." Aim: To evaluate the efficacy of Ayurvedic medicine on associated signs and symptoms of carcinoma gall bladder following conventional anti-cancer therapy. Objective: To evaluate the QOL of the studied patient of carcinoma gall bladder following conventional anti-cancer therapy. Materials and methods: 20 patients suffering from the associated signs and symptoms of carcinoma gall bladder following conventional anti-cancer therapy were enrolled and randomly divided into two groups, i.e., Study Group B, Brihat Loknath Rasa 250 mg with lukewarm water, Mahashankh vati 250 mg with buttermilk, and Drakshavleha 6 gm with milk. In Control Group A, patients undergoing modern medicine were observed for 60 days. Results and Conclusion: The analysis of the relief percentage of the (Overall therapy) shows that the % relief for Study Group patients was 43.40% and the relief for Control Group was 38.68%. In conclusion, Ayurveda has the potential for symptomatic management of gallbladder cancer (GBC) by aligning with Pitta pradhan sannipatika Gulma. While a holistic approach and Ayurvedic principles show promise, more research in Ayurvedic oncology is required for validation.
{"title":"ROLE OF AYURVEDIC MEDICINES ON CARCINOMA GALL BLADDER AFTER CONVENTIONAL ANTI-CANCER THERAPY: A RANDOMISED CONTROL TRIAL","authors":"Priyanka Katru, S. Porte, Ashwani Sharma","doi":"10.7897/2277-4343.15112","DOIUrl":"https://doi.org/10.7897/2277-4343.15112","url":null,"abstract":"Gallbladder cancer (GBC) arises from the cystic duct and gallbladder lining, presenting as a thickening in the bile duct wall or a diffuse mass. Arbuda and Gulma are considered malignant tumours in Ayurveda. Acharya Charaka associates Gulma, a type of shotha, with the pittashaya (gall bladder) among the five adhishthans. Acharya Sushruta defines Gulma as \"any granthi between hruday and Basti pradesh.\" Aim: To evaluate the efficacy of Ayurvedic medicine on associated signs and symptoms of carcinoma gall bladder following conventional anti-cancer therapy. Objective: To evaluate the QOL of the studied patient of carcinoma gall bladder following conventional anti-cancer therapy. Materials and methods: 20 patients suffering from the associated signs and symptoms of carcinoma gall bladder following conventional anti-cancer therapy were enrolled and randomly divided into two groups, i.e., Study Group B, Brihat Loknath Rasa 250 mg with lukewarm water, Mahashankh vati 250 mg with buttermilk, and Drakshavleha 6 gm with milk. In Control Group A, patients undergoing modern medicine were observed for 60 days. Results and Conclusion: The analysis of the relief percentage of the (Overall therapy) shows that the % relief for Study Group patients was 43.40% and the relief for Control Group was 38.68%. In conclusion, Ayurveda has the potential for symptomatic management of gallbladder cancer (GBC) by aligning with Pitta pradhan sannipatika Gulma. While a holistic approach and Ayurvedic principles show promise, more research in Ayurvedic oncology is required for validation.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"41 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140415677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tejashwini M Rajanal, R. S, Shubha Pu, Suchitra N Prabhu, Chaitra Hebbar
Introduction: The quality of drugs is the prime and basic need of present pharmacies to safeguard the well-being and efficacy of drugs when it comes to herbal origin. The Ayurveda system of medicine stretched worldwide due to the increased side effects of synthetic drugs, lack of remedies for several chronic diseases, microbial resistance, high cost of synthetic drugs, developing diseases, and, most importantly, bacterial diseases transferred through polluted water. Bhasma (ash) form is a potent Ayurvedic pharmaceutical with biologically active and powerful healing preparation. These Bhasma (ash) possess a wide range of therapeutic efficacy and are considered superior because of their small dose, quick action, palatability, and longer shelf life. Dhavadi Bhasma is one of the Jalashuddhikarana yogas (formulations) mentioned in the Kriyakoumudi-A Malayalam textbook of Visha chikitsa (treatment), which helps to enhance its properties and retain its benefits. Aims: The present study focuses on the pharmaceutical-analytical study of Dhavadi Bhasma (ash) with various parameters. Materials and Methods: The method of preparation and the comprehensive standardization of Dhavadi Bhasma formulation is done per the standard testing protocol and accentuates its properties and actions in Jalashuddhikarana (water purification). Observation and results: Dhavadi Bhasma, explained by Kriyakoumudi, contains eight drugs, all of which have Vishahara (anti-poisonous) and Krimigna (anti-bacterial) properties and can be used in water purification.
{"title":"PHARMACEUTICAL ANALYTICAL STUDY OF DHAVADI BHASMA","authors":"Tejashwini M Rajanal, R. S, Shubha Pu, Suchitra N Prabhu, Chaitra Hebbar","doi":"10.7897/2277-4343.1519","DOIUrl":"https://doi.org/10.7897/2277-4343.1519","url":null,"abstract":"Introduction: The quality of drugs is the prime and basic need of present pharmacies to safeguard the well-being and efficacy of drugs when it comes to herbal origin. The Ayurveda system of medicine stretched worldwide due to the increased side effects of synthetic drugs, lack of remedies for several chronic diseases, microbial resistance, high cost of synthetic drugs, developing diseases, and, most importantly, bacterial diseases transferred through polluted water. Bhasma (ash) form is a potent Ayurvedic pharmaceutical with biologically active and powerful healing preparation. These Bhasma (ash) possess a wide range of therapeutic efficacy and are considered superior because of their small dose, quick action, palatability, and longer shelf life. Dhavadi Bhasma is one of the Jalashuddhikarana yogas (formulations) mentioned in the Kriyakoumudi-A Malayalam textbook of Visha chikitsa (treatment), which helps to enhance its properties and retain its benefits. Aims: The present study focuses on the pharmaceutical-analytical study of Dhavadi Bhasma (ash) with various parameters. Materials and Methods: The method of preparation and the comprehensive standardization of Dhavadi Bhasma formulation is done per the standard testing protocol and accentuates its properties and actions in Jalashuddhikarana (water purification). Observation and results: Dhavadi Bhasma, explained by Kriyakoumudi, contains eight drugs, all of which have Vishahara (anti-poisonous) and Krimigna (anti-bacterial) properties and can be used in water purification.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"16 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140412523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hepatic steatosis is defined as the accumulation of intrahepatic fat of at least 5% of liver weight, which may lead to metabolic dysfunction and inflammation in the liver. It is a common condition in 7% to 30% of people and gets worse over time into liver fibrosis, cirrhosis, and hepatocellular carcinoma. Modern science illustrates that there is no specific treatment protocol for fatty liver disease (FLD) except a healthy diet and exercise. In this case report, an individual was diagnosed with hepatosteatosis, having symptoms- pain in the abdomen with heartburn, burning in the throat, excessive thirst, belching, lassitude, constipation, nausea, and a yellowish appearance in the eyes. Fibroscan shows 77% of fat deposition with fibrosis (Grade F1). Based on the cardinal features of Udarashula, Chardi, and Peetanetra, the patient was assigned as a case of Parinam Shula and treated according to the line of management of Shula Chikitsa. After 3 months of drug intervention, there is a significant reduction in symptoms. Fibroscan shows a significant reduction in fat deposition (77% to 24%) with changes in fibrosis grading (from F1 to F0).
{"title":"EFFECTIVENESS OF YASHTIMADHU CHURNA, AMALAKI RASAYANA AND PHALATRIKADI KWATH IN HEPATOSTEATOSIS: A CASE REPORT","authors":"Shushma Upadhyay, Y. K. Pandey","doi":"10.7897/2277-4343.1515","DOIUrl":"https://doi.org/10.7897/2277-4343.1515","url":null,"abstract":"Hepatic steatosis is defined as the accumulation of intrahepatic fat of at least 5% of liver weight, which may lead to metabolic dysfunction and inflammation in the liver. It is a common condition in 7% to 30% of people and gets worse over time into liver fibrosis, cirrhosis, and hepatocellular carcinoma. Modern science illustrates that there is no specific treatment protocol for fatty liver disease (FLD) except a healthy diet and exercise. In this case report, an individual was diagnosed with hepatosteatosis, having symptoms- pain in the abdomen with heartburn, burning in the throat, excessive thirst, belching, lassitude, constipation, nausea, and a yellowish appearance in the eyes. Fibroscan shows 77% of fat deposition with fibrosis (Grade F1). Based on the cardinal features of Udarashula, Chardi, and Peetanetra, the patient was assigned as a case of Parinam Shula and treated according to the line of management of Shula Chikitsa. After 3 months of drug intervention, there is a significant reduction in symptoms. Fibroscan shows a significant reduction in fat deposition (77% to 24%) with changes in fibrosis grading (from F1 to F0).","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140415019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Arjun M, Archana P. Gharote, Salini P, D. Ramugade, Reshma T
Appendicitis is inflammation of the vermiform appendix. It has an approximate incidence of 233 per 100,000 people. This is a case of a 7-year-old boy diagnosed with appendicitis and suggested appendicectomy by the modern fraternity. His parents were reluctant to do surgery and took him to our Outpatient Department (OPD). The appendix was distended with a diameter of 7.3 mm in the Ultra Sono Graphy (USG) report. After detailed evaluation and dosha dushya assessment, the treatment adopted was that of Pitta Kapha Gulma and Antar vidradhi and given OP-level treatment. Pathya ahara (appropriate diet regimen) was strictly advised along with medicines. After one month of treatment, the size of the appendix was reduced to 5.3 mm. The medicines were discontinued and Charngeryadi ghrita was given for 2 months. The patient was completely recovered, and no recurrence has been observed.
{"title":"MANAGEMENT OF APPENDICITIS THROUGH AYURVEDIC MEDICINES: A CASE REPORT","authors":"Arjun M, Archana P. Gharote, Salini P, D. Ramugade, Reshma T","doi":"10.7897/2277-4343.1517","DOIUrl":"https://doi.org/10.7897/2277-4343.1517","url":null,"abstract":"Appendicitis is inflammation of the vermiform appendix. It has an approximate incidence of 233 per 100,000 people. This is a case of a 7-year-old boy diagnosed with appendicitis and suggested appendicectomy by the modern fraternity. His parents were reluctant to do surgery and took him to our Outpatient Department (OPD). The appendix was distended with a diameter of 7.3 mm in the Ultra Sono Graphy (USG) report. After detailed evaluation and dosha dushya assessment, the treatment adopted was that of Pitta Kapha Gulma and Antar vidradhi and given OP-level treatment. Pathya ahara (appropriate diet regimen) was strictly advised along with medicines. After one month of treatment, the size of the appendix was reduced to 5.3 mm. The medicines were discontinued and Charngeryadi ghrita was given for 2 months. The patient was completely recovered, and no recurrence has been observed.","PeriodicalId":14253,"journal":{"name":"International journal of research in ayurveda and pharmacy","volume":"8 13","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140409860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：